| Dr John Gregory Amspaugh, MD | |
|
5501 Nw 86th St, Ste 300, Johnston, IA 50131 | |
| (515) 875-9035 | |
| (515) 875-9036 |
| Full Name | Dr John Gregory Amspaugh |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 5501 Nw 86th St, Johnston, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588647820 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-39558 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| On With Life Inc | 4385553965 | 126 |
| The Iowa Clinic Pc | 4082513742 | 273 |
News Archive
Amylin Pharmaceuticals, Inc. today announced results from new analyses of previously completed clinical studies demonstrating that patients with type 2 or type 1 diabetes achieved a greater proportion of blood glucose measurements in the normal range when SYMLIN (pramlintide acetate) injection treatment was used along with insulin.
A new knee-surgery device investigated by University of Missouri-Columbia researchers that will help to repair meniscus tears, which were previously defined as irreparable, has been approved by the FDA for use in humans.
AutoImmune Inc. today announced that its stockholders have voted in favor of the company's voluntary dissolution pursuant to a Plan of Complete Liquidation and Dissolution at a special meeting of stockholders held on May 11, 2010. Stockholders voted overwhelmingly in favor of the dissolution of the company pursuant to the Plan of Complete Liquidation and Dissolution, with the proposal receiving an affirmative vote from approximately 99% of the votes cast at the special meeting of stockholders.
A new study published in the journal JAMA Internal Medicine in March 2020 reports the striking efficacy of the drug gabapentin in helping people with alcohol use disorder (AUD) with their alcohol withdrawal symptoms.
Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced today the company's clinical program to treat Adrenoleukodystrophy (ALD). The company is developing a gene therapy product in collaboration with Professor Patrick Aubourg and Doctor Nathalie Cartier of the National Institute of Health and Medical Research (INSERM).
› Verified 9 days ago
| Entity Name | The Iowa Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346233178 PECOS PAC ID: 4082513742 Enrollment ID: O20040102000222 |
News Archive
Amylin Pharmaceuticals, Inc. today announced results from new analyses of previously completed clinical studies demonstrating that patients with type 2 or type 1 diabetes achieved a greater proportion of blood glucose measurements in the normal range when SYMLIN (pramlintide acetate) injection treatment was used along with insulin.
A new knee-surgery device investigated by University of Missouri-Columbia researchers that will help to repair meniscus tears, which were previously defined as irreparable, has been approved by the FDA for use in humans.
AutoImmune Inc. today announced that its stockholders have voted in favor of the company's voluntary dissolution pursuant to a Plan of Complete Liquidation and Dissolution at a special meeting of stockholders held on May 11, 2010. Stockholders voted overwhelmingly in favor of the dissolution of the company pursuant to the Plan of Complete Liquidation and Dissolution, with the proposal receiving an affirmative vote from approximately 99% of the votes cast at the special meeting of stockholders.
A new study published in the journal JAMA Internal Medicine in March 2020 reports the striking efficacy of the drug gabapentin in helping people with alcohol use disorder (AUD) with their alcohol withdrawal symptoms.
Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced today the company's clinical program to treat Adrenoleukodystrophy (ALD). The company is developing a gene therapy product in collaboration with Professor Patrick Aubourg and Doctor Nathalie Cartier of the National Institute of Health and Medical Research (INSERM).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Gregory Amspaugh, MD Po Box 424, Des Moines, IA 50302-0424 Ph: (515) 875-9255 | Dr John Gregory Amspaugh, MD 5501 Nw 86th St, Ste 300, Johnston, IA 50131 Ph: (515) 875-9035 |
News Archive
Amylin Pharmaceuticals, Inc. today announced results from new analyses of previously completed clinical studies demonstrating that patients with type 2 or type 1 diabetes achieved a greater proportion of blood glucose measurements in the normal range when SYMLIN (pramlintide acetate) injection treatment was used along with insulin.
A new knee-surgery device investigated by University of Missouri-Columbia researchers that will help to repair meniscus tears, which were previously defined as irreparable, has been approved by the FDA for use in humans.
AutoImmune Inc. today announced that its stockholders have voted in favor of the company's voluntary dissolution pursuant to a Plan of Complete Liquidation and Dissolution at a special meeting of stockholders held on May 11, 2010. Stockholders voted overwhelmingly in favor of the dissolution of the company pursuant to the Plan of Complete Liquidation and Dissolution, with the proposal receiving an affirmative vote from approximately 99% of the votes cast at the special meeting of stockholders.
A new study published in the journal JAMA Internal Medicine in March 2020 reports the striking efficacy of the drug gabapentin in helping people with alcohol use disorder (AUD) with their alcohol withdrawal symptoms.
Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced today the company's clinical program to treat Adrenoleukodystrophy (ALD). The company is developing a gene therapy product in collaboration with Professor Patrick Aubourg and Doctor Nathalie Cartier of the National Institute of Health and Medical Research (INSERM).
› Verified 9 days ago
Dr. Abbie D Ruisch, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5501 Nw 86th St, Suite 300, Johnston, IA 50131 Phone: 515-875-9035 Fax: 515-875-9036 | |
Carlos Alarcon-schroder, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5615 Nw 86th St, Johnston, IA 50131 Phone: 515-643-6000 Fax: 515-643-6001 | |
Amy Fulton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5615 Nw 86th St, Johnston, IA 50131 Phone: 515-643-6000 Fax: 515-643-6001 | |
Jaspreet Singh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5615 Nw 86th St, Johnston, IA 50131 Phone: 515-643-6000 Fax: 515-643-6001 | |
Dr. Danny Paul Smith, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7105 Nw 70th Ave, Johnston, IA 50131 Phone: 515-252-4317 | |
Thomas Charles Evans, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7005 Nw Beaver Dr, Johnston, IA 50131 Phone: 515-270-6287 | |
Lindsey Hohulin, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 5501 Nw 86th St Ste 300, Johnston, IA 50131 Phone: 515-875-9035 Fax: 515-875-9036 |